tiprankstipranks
Advertisement
Advertisement

GB:0QAV Stock Latest News

Nanobiotix price target raised to EUR 34 from EUR 32 at H.C. Wainwright
The FlyNanobiotix price target raised to EUR 34 from EUR 32 at H.C. Wainwright
2d ago
NBTX
PremiumCompany Announcements
Nanobiotix Earnings Call: Deeper J&J Ties, Lower Loss
9d ago
Nanobiotix price target raised to $36 from $26 at Guggenheim
PremiumThe Fly
Nanobiotix price target raised to $36 from $26 at Guggenheim
13d ago
NBTX
Nanobiotix: Late-Stage NBTXR3 Pipeline and Partnerships Underpin Buy-Rated Risk-Reward Profile
PremiumRatings
Nanobiotix: Late-Stage NBTXR3 Pipeline and Partnerships Underpin Buy-Rated Risk-Reward Profile
14d ago
NBTX
Nanobiotix price target raised to $37 from $26 at Leerink
PremiumThe Fly
Nanobiotix price target raised to $37 from $26 at Leerink
14d ago
NBTX
Robust Phase 2 CONVERGE Data for JNJ-1900 Underpin Buy Rating and €32 Price Target on Nanobiotix
PremiumRatingsRobust Phase 2 CONVERGE Data for JNJ-1900 Underpin Buy Rating and €32 Price Target on Nanobiotix
16d ago
NBTX
Nanobiotix price target raised to EUR 32 from EUR 23 at H.C. Wainwright
Premium
The Fly
Nanobiotix price target raised to EUR 32 from EUR 23 at H.C. Wainwright
16d ago
NBTX
Nanobiotix presents first data from CONVERGE study
Premium
The Fly
Nanobiotix presents first data from CONVERGE study
16d ago
JNJ
NBTX
Nanobiotix says ‘no such intention’ for company to acquire control
PremiumThe Fly
Nanobiotix says ‘no such intention’ for company to acquire control
21d ago
NBTX
Nanobiotix initiated with a Buy at TD Cowen
PremiumThe Fly
Nanobiotix initiated with a Buy at TD Cowen
2M ago
NBTX
Nanobiotix: Differentiated Radiotherapy Enhancer, J&J Partnership, and Multi-Indication Pipeline Undervalue Long-Term Upside, Supporting Buy Rating
PremiumRatings
Nanobiotix: Differentiated Radiotherapy Enhancer, J&J Partnership, and Multi-Indication Pipeline Undervalue Long-Term Upside, Supporting Buy Rating
2M ago
NBTX
Undervalued Royalty Stream and De‑Risked Partnership Economics Underpin Nanobiotix Buy Rating
PremiumRatings
Undervalued Royalty Stream and De‑Risked Partnership Economics Underpin Nanobiotix Buy Rating
3M ago
NBTX
Strategic Financial and Operational Advancements Propel Nanobiotix to a Buy Rating
PremiumRatingsStrategic Financial and Operational Advancements Propel Nanobiotix to a Buy Rating
5M ago
NBTX
Nanobiotix price target raised to EUR 23 from EUR 20 at H.C. Wainwright
Premium
The Fly
Nanobiotix price target raised to EUR 23 from EUR 20 at H.C. Wainwright
5M ago
NBTX
Nanobiotix’s Strategic Financing and Clinical Expansion Signal Strong Buy Opportunity
Premium
Ratings
Nanobiotix’s Strategic Financing and Clinical Expansion Signal Strong Buy Opportunity
5M ago
NBTX
Nanobiotix enters royalty-based financing pact with HealthCare Royalty for $71M
PremiumThe Fly
Nanobiotix enters royalty-based financing pact with HealthCare Royalty for $71M
6M ago
NBTX
Nanobiotix provides update on JNJ-1900 after Johnson & Johnson transfer
PremiumThe Fly
Nanobiotix provides update on JNJ-1900 after Johnson & Johnson transfer
6M ago
JNJ
NBTX
Nanobiotix price target raised to EUR 20 from EUR 13 at H.C. Wainwright
PremiumThe Fly
Nanobiotix price target raised to EUR 20 from EUR 13 at H.C. Wainwright
7M ago
NBTX
Nanobiotix presents data from JNJ-1900 dose escalation, expansion study cohorts
PremiumThe Fly
Nanobiotix presents data from JNJ-1900 dose escalation, expansion study cohorts
7M ago
JNJ
NBTX
Nanobiotix price target raised to EUR 13 from EUR 10 at H.C. Wainwright
PremiumThe FlyNanobiotix price target raised to EUR 13 from EUR 10 at H.C. Wainwright
7M ago
NBTX
Nanobiotix price target raised to $14 from $9 at Leerink
Premium
The Fly
Nanobiotix price target raised to $14 from $9 at Leerink
7M ago
NBTX
Nanobiotix announces new results from JNJ-1900 study
Premium
The Fly
Nanobiotix announces new results from JNJ-1900 study
7M ago
JNJ
NBTX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >